OxThera Secures $10M Investment to Continue Clinical Programs

Swedish biopharmaceutical firm OxThera has received $10 million from a syndicate of new investors, led by Kurma Partners, including IdInvest Partners and Mayo Clinic, to continue its major clinical programs.
Pharmaceutical Business Review